A detailed history of Acadian Asset Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 102,272 shares of EBS stock, worth $845,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,272
Previous 108,566 5.8%
Holding current value
$845,789
Previous $739,000 15.43%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.72 - $14.77 $36,001 - $92,962
-6,294 Reduced 5.8%
102,272 $853,000
Q2 2024

Aug 06, 2024

BUY
$1.86 - $6.98 $146,992 - $551,615
79,028 Added 267.55%
108,566 $739,000
Q1 2024

May 10, 2024

SELL
$1.5 - $3.41 $290,809 - $661,106
-193,873 Reduced 86.78%
29,538 $74,000
Q4 2023

Feb 13, 2024

BUY
$1.82 - $3.16 $273,087 - $474,151
150,048 Added 204.53%
223,411 $535,000
Q3 2023

Nov 13, 2023

BUY
$3.17 - $7.91 $232,560 - $580,301
73,363 New
73,363 $249,000
Q1 2023

May 11, 2023

SELL
$7.79 - $16.29 $1.46 Million - $3.06 Million
-187,974 Reduced 98.63%
2,610 $27,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $1.47 Million - $2.87 Million
133,751 Added 235.34%
190,584 $2.25 Million
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $381,589 - $679,985
18,994 Added 50.2%
56,833 $1.19 Million
Q2 2022

Aug 09, 2022

SELL
$27.42 - $43.63 $483,990 - $770,113
-17,651 Reduced 31.81%
37,839 $1.18 Million
Q1 2022

May 12, 2022

SELL
$36.48 - $52.22 $1.83 Million - $2.61 Million
-50,060 Reduced 47.43%
55,490 $2.28 Million
Q4 2021

Feb 10, 2022

SELL
$33.11 - $55.01 $1.33 Million - $2.21 Million
-40,084 Reduced 27.52%
105,550 $4.59 Million
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $1.29 Million - $1.7 Million
-25,811 Reduced 15.05%
145,634 $7.29 Million
Q2 2021

Aug 11, 2021

BUY
$56.61 - $80.46 $3.59 Million - $5.1 Million
63,434 Added 58.73%
171,445 $10.8 Million
Q1 2021

May 11, 2021

SELL
$86.23 - $125.19 $3.1 Million - $4.51 Million
-35,989 Reduced 24.99%
108,011 $10 Million
Q4 2020

Feb 11, 2021

BUY
$79.17 - $111.47 $2.29 Million - $3.22 Million
28,897 Added 25.11%
144,000 $12.9 Million
Q3 2020

Nov 09, 2020

BUY
$81.91 - $134.94 $151,205 - $249,099
1,846 Added 1.63%
115,103 $11.9 Million
Q2 2020

Aug 12, 2020

BUY
$54.33 - $89.52 $6.15 Million - $10.1 Million
113,257 New
113,257 $8.96 Million
Q1 2020

May 11, 2020

SELL
$49.34 - $68.76 $14.8 Million - $20.6 Million
-299,673 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$51.21 - $59.06 $15.3 Million - $17.7 Million
299,673 New
299,673 $16.2 Million
Q3 2019

Nov 07, 2019

SELL
$40.6 - $57.2 $21.1 Million - $29.8 Million
-520,302 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$39.92 - $53.86 $7.93 Million - $10.7 Million
-198,682 Reduced 27.63%
520,302 $25.1 Million
Q1 2019

May 09, 2019

SELL
$48.23 - $66.16 $10.3 Million - $14.1 Million
-213,720 Reduced 22.91%
718,984 $36.3 Million
Q4 2018

Feb 07, 2019

SELL
$55.63 - $73.24 $18.6 Million - $24.5 Million
-334,806 Reduced 26.41%
932,704 $55.3 Million
Q3 2018

Oct 30, 2018

SELL
$52.05 - $66.51 $13.1 Million - $16.7 Million
-251,836 Reduced 16.58%
1,267,510 $83.4 Million
Q2 2018

Jul 24, 2018

SELL
$48.33 - $55.64 $8.72 Million - $10 Million
-180,477 Reduced 10.62%
1,519,346 $76.7 Million
Q1 2018

Apr 12, 2018

BUY
$44.44 - $54.39 $11.3 Million - $13.8 Million
254,411 Added 17.6%
1,699,823 $89.5 Million
Q4 2017

Jan 18, 2018

BUY
$37.77 - $47.75 $3.2 Million - $4.05 Million
84,713 Added 6.23%
1,445,412 $67.2 Million
Q3 2017

Oct 13, 2017

BUY
$34.14 - $40.45 $46.5 Million - $55 Million
1,360,699
1,360,699 $55 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $412M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.